Abstract
Intrauterine growth restriction (IUGR) is an adverse pregnancy outcome associated with significant perinatal and pediatric morbidity and mortality, and an increased risk of chronic disease later in adult life. While a number of maternal, fetal and environmental factors are known causes of IUGR, the majority of IUGR cases are of unknown cause. These IUGR cases are frequently associated with placental insufficiency, possibly as a result of placental maldevelopment. Understanding the molecular mechanisms of abnormal placental development in IUGR associated with placental insufficiency is therefore of increasing importance. Here, we review our understanding of transcriptional control of normal placental development as well as human IUGR associated with placental insufficiency. We also assess the potential for understanding transcriptional control as a means for revealing new molecular targets for the detection, diagnosis and clinical management of IUGR associated with placental insufficiency.
Original language | English |
---|---|
Pages (from-to) | 225-230 |
Number of pages | 6 |
Journal | Fetal Diagnosis and Therapy |
Volume | 32 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Dec 2012 |
Externally published | Yes |
Keywords
- Intrauterine growth restriction
- Low birth weight
- Perinatal morbidity
- Perinatal mortality
- Placental insufficiency
- Small for gestational age